Takayuki Matsumae

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy

Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori et al. · Cancers · 2022 · 84 citations · Full text

Medicine, Immunology, Oncology +17

Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy

Takayuki Matsumae, Takahiro Kodama, Yuta Myojin et al. · Cancers · 2022 · 66 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter

Takeshi Yamashina, Takehiko Tumura, Takanori Maruo et al. · Endoscopy International Open · 2018 · 26 citations · Full text

Medicine, Oncology, Surgery +17

Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral

Takayuki Matsumae, Takahiro Kodama, Yuki Tahata et al. · Cancers · 2023 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17

Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity

Junya Okabe, Takahiro Kodama, Yu Sato et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 10 citations · Full text

Medicine, Cancer Biology, Oncology +17